Objective: To explore the clinical value of individualized nursing intervening in the treatment of patients with cirrhosis of the liver cirrhosis.Methods: One hundred and ten patients with decompensated liver cirrhosis were selected and randomized into individualized care group and routine nursing group, 55 cases in each. Both groups were given basic treatment. Treatment effect and treatment compliance of the two groups of patients under different care measures were compared. Results: There was no significant difference in the serum ALT, AST, ALB, TBIL and PT serum HBV-DNA between the individualized care group and the conventional nursing group before treatment(P>0.05). After treatment, the levels of serum ALT, AST, TBIL, PT and serum HBV-DNA in the individualized care group were lower than those in the conventional nursing group(P<0.05). The level of ALB in the individualized nursing group was higher than that in the routine nursing group(P<0.05); After treatment, as for liver function of Child-pugh classification, in individualized care group, 20.00% were in grade A,74.55% grade B, 5.45% grade C; while in routine nursing group, 7.27% were in grade A, 78.18% grade B, 14.55% grade C. The difference was statistically significant(Z=-2.351, P<0.05); In the course of treatment, the total compliance rate of the individualized nursing group was 80.00%, the partial compliance rate was 18.18%, the non-compliance rate was 1.82%, the complete compliance rate of the conventional nursing group was 60.00%, the partial compliance rate was 32.73%, the non-compliance rate was 7.27%,the difference between the two groups was statistically significant(P<0.05). Conclusion: Individualized nursing intervening can significantly improve the treatment compliance in the course of treatment of patients with liver cirrhosis and results in positive effect on the treatment. |
[1] 陈凌华,林英,李凤,等.健康教育对肝硬化患者家庭生活质量的影响[J].中华健康管理学杂志,2014,8(5):343-346.
[2] 谭柳纯,顾春妮,黄雪霞,等.基于微信构建肝硬化患者出院健康管理平台的研究[J].护理学报,2015,22(23):68-69.
[3] 陈吐芬,江晓静.聚乙二醇干扰素α-2a联合利巴韦林治疗慢性丙型肝炎和代偿期丙型肝炎肝硬化的对比研究[J].华南国防医学杂志,2014,28(8):743-747.
[4] 张曹庚,项晓刚,刘柯慧,等.基因1型慢性丙型肝炎代偿期肝硬化患者抗病毒治疗后的长期随访研究[J].肝脏,2016,21(6):434-437.
[5] WANG Q,WANG Y,GAO J,et al.Development of a self-management behaviour scale for liver cirrhosis[J].Inter J Nursing Sci,2014,2(1):73-79.
[6] GOLDBERG D S,FALLON M B.The Art and Science of Diagnosing and Treating Lung and Heart Disease Secondary to Liver Disease[J].Clin Gastroenterol Hepatol,2015,13(12):2118-2127.
[7] 齐越,秦杰,邱坤鹏,等.认知干预对肝硬化腹泻患者的效果观察[J].现代生物医学进展,2014,14(29):5761-5764.
[8] 王俊鲜,张莉.高龄慢性丙肝患者干扰素治疗并发重度血小板减少症的护理[J].中日友好医院学报,2016,30(1):60-60.
[9] 杨辉,周筱燕,周岩芬,等.奥曲肽联合隔下逐瘀汤治疗肝硬化上消化道出血患者临床疗效和血流动力学的变化[J].实用肝脏病杂志,2016,19(4):459-462.
[10] BLACKHAM A U,SWETT K,LEVINE E A,et al.Surgical management of colorectal cancer metastases to the liver:multimodality approach and a single institutional experience[J].Colorectal Canc,2015,2(1):73-88.
[11] 陈洁,周俊霞.肝炎肝硬化患者出院后延续护理的效果研究[J].实用临床医药杂志,2014,18(2):83-84.
[12] HOU P W,FU P K,HSU H C,et al.Traditional Chinese medicine in patients with osteoarthritis of the knee[J].J Trad Compl Med,2015,47(4):182-196.
[13] 贺世春,王东霞,巫贵成,等.外出务工慢性乙型肝炎患者管理现状及对策研究[J].重庆医学,2016,45(20):2810-2813.
[14] 刘亮.肝硬化并上消化道出血48例临床疗效分析[J].湖南中医药大学学报,2014,34(2):8-9.
[15] HARPER P,SARDH E.Management of acute intermittent porphyria[J].Expert Opin Orphan Drugs,2014,2(4):349-368. |